FeesSafety
Pluang+

Agree Realty shows strong fundamentals but limited near-term upside; preferred stock yield faces interest rate risks.

Company Fundamentals
22 Sep 2026
Seeking Alpha
View Source
Neutral
Agree Realty shows strong fundamentals but limited near-term upside; preferred stock yield faces interest rate risks.

Agree Realty Corporation maintains a robust portfolio of 2,824 retail properties and strong credit metrics, including a low secured debt ratio and high asset coverage. Its common stock trades at a 1.34x price-to-book with a 5.21% AFFO yield, supporting a 'hold' rating due to limited near-term upside potential. The preferred stock offers a 6.64% yield and investment-grade ratings but is challenged by interest rate risks and a narrower spread, making other investments more attractive. Overall, Agree Realty's conservative balance sheet underscores its credit strength and stable position in retail property leasing.

Agree Realty's preferred stock yield of 6.64% stands out as a key figure in fixed income discussions. For readers following real estate sector stocks, here is Pluang's market snapshot as of Sep 22, 2026 14:41 WIB: Among 25 priced US real estate stocks tradable on Pluang, 21 rose and 4 fell. Notable movers include LTC Properties Inc at USD 43.02 with a 1.08% increase and 100% buy order activity, Jones Lang LaSalle Inc at USD 339.86 with a 1.03% rise, and KE Holdings Inc at USD 16.34 with a 1.39% decline. Typical hold times vary from 22 to 86 days across these stocks.

More News

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...

Company Fundamentals
Bullish
1 hour ago
Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...

Company Fundamentals
Bullish
1 hour ago
AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
3 hours ago
BlackRock TCP Capital remains a sell amid structural challenges despite high dividend yield.

BlackRock TCP Capital remains a sell amid structural challenges despite high dividend yield.

BlackRock TCP Capital (TCPC) continues to face structural issues and sector headwinds, leading to a sell recommendation despite trading at a deep discount to its net asset value (NAV). The company has restructured its portfolio, including a significa...

Market News
Bearish
4 hours ago
Blockstream opens Swiss office to offer Bitcoin infrastructure consulting for European financial firms

Blockstream opens Swiss office to offer Bitcoin infrastructure consulting for European financial firms

Blockstream has opened a new office in Lugano, Switzerland, launching consulting services to help banks and asset managers design and implement Bitcoin infrastructure. The service covers technical planning, system architecture, and integration for pr...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App